butorphanol has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, F; Shen, T; Wu, Q; Zhang, W | 1 |
| Jennings, RB; Reimer, KA; Schwartz, LM | 1 |
2 other study(ies) available for butorphanol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Multiple pathways are responsible to the inhibitory effect of butorphanol on OGD/R-induced apoptosis in AC16 cardiomyocytes.
Topics: Apoptosis; Butorphanol; Caspase 3; Glucose; Humans; Myocardial Ischemia; Myocytes, Cardiac; Oxygen; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reperfusion; Vascular Endothelial Growth Factor A | 2022 |
Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Butorphanol; Cardiotonic Agents; Coronary Circulation; Coronary Vessels; Death; Dogs; Female; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Pentobarbital; Premedication; Regional Blood Flow | 1997 |